Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DH Diagnostics is a Danaher-affiliated diagnostics company focused on accelerating the development and commercialization of companion diagnostics and complementary diagnostics for precision medicine. The company operates CLIA- and CAP-certified laboratory centers designed to bring multiple Danaher diagnostic technologies and assay capabilities under one roof. Its model is intended to reduce hand-offs across biomarker validation, translational research, clinical trial assay development, and global deployment workflows. DH Diagnostics appears to function primarily as a diagnostics development and services platform rather than as a therapeutic drug developer, with a particular emphasis on oncology-related precision diagnostics and pharma partnering.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DH Diagnostics.